Nelson has been manufacturing AI devices since 2003. Nelson is ISO9001:2000 certified by TÜV Rheinland Product Safety Gmbh of Germany. Nelson AI products are produced in Medical Grade Clean Room, which assures products of high hygiene and quality level.
Nelson annual production capacity is 50 million catheters and 40 million semen packs. Nelson AI products have been exporting to 28 countries, such as Japan, Korea, Australia, Canada, USA, Denmark, Germany, Spain, the Netherlands, Italy, etc. Nelson products are very well recognized and popular to users in developed countries.
Our products range various from AI devices for pig, cattle, goat, rabbit and turkey, farm production tools and bio-security protection products. Nelson is pleased to make products with your private labels and its high quality control will be a plus to your valuable brands.
Nelson and ITSI Canada have set up a joint venture company named Sino-Canada DOFU AI Technology Co Ltd, which markets AI products in China. DOFU's sales model is Tele-marketing and Internet-marketing plus key-customer service. DOFU is honored to represent your products in Chinese market and win the prosperous success for you!
OEM Manufacturing Domestic Marketing
Nelson expects win-win cooperation with you and wishes our high quality AI products will benefit farmers all over the world!
Strategic Partnership for IMV Technologies in china
Shanghai, China, November 25th, 2011: A strategic agreement has been signed between IMV Technologies
and Nelson Medical.
Present in China for 30 years and endowed with a sales structure for more than 10 years, IMV has just signed
a strategic partnership agreement for the Chinese market with Nelson Medical;
Nelson Medical designs, manufactures, and markets disposable medical (catheters, transfusion kits...) and
porcine animal reproduction products. Located in Shanghai, Nelson has a modern industrial site equipped
with class 100,000 white rooms, ISO 9001:2000 and CE certified, with 150 employees.
IMV Technologies is the global leader in reproduction biotechnologies, a pioneer in veterinary reproduction
techniques. Endowed with a new industrial site and subsidiaries strategically located in 5 countries, IMV
Technologies is also present on the Bio Banking and medically assisted procreation markets through its
subsidiary Cryo Bio System (CBS).
This partnership will allow IMV Technologies to accelerate its growth on the Chinese market with the
availability of a local logistics andmanufacturing hub. This will provide for developing a parallel product
range offered by CBS in the medical sector.
